3rd Virtual Clinical Trials

November 16-17, 2020

Online Livestream

What To Expect

The 3rd Virtual Clinical Trials Conference is the industry’s recognized leading event for overcoming technology barriers, accelerating the adoption of digital trials, and building team capabilities around these now-essential methods. Our speaking faculty of over 25 industry thought-leaders guide you through the necessary changes in your clinical infrastructure, while emphasizing how to always put patients first. No other event offers so many all-new insights on comparing methods for virtual studies, rising to the challenges of incorporating AI into remote trials, and reorienting virtual trial design around the patient perspective. Join us to revolutionize your clinical research pipeline – and turn today’s emergency into tomorrow’s opportunity.

Hilton East Brunswick

Image

3 Tower Center Blvd.
East Brunswick, NJ 08816

(732) 828-2000

Hotel Website

About the Chairperson

Image

Dr. Matthew T. Roe has been a faculty member at Duke University School of Medine and the Duke Clinical Research Institute (DCRI) since 1999. As a senior investigator at the DCRI, he has been the principal investigator for numerous phase II-IV cardiovascular clinical trials and is currently a co-principal investigator for the ADAPTABLE trial—the first large-scale pragmatic trials being conducted in the PCORnet network. He has also served in leadership roles for several observational registries focusing upon the treatment and outcomes of patients with cardiovascular disease and has served as the Director of the DCRI Clinical Research Fellowship since 2010.

Featured Speakers

Image

Craig Lipset

Head of Clinical Innovation
Pfizer

Image

Jeff Kingsley

Chief Executive Officer
IACT Health 

Image

Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice
Deloitte

Image

Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Why Attend?

  • Flag the most important successes in post-COVID clinical trial modifications
  • Compare and contrast different models of remote trials
  • Visualize new clinical research and patient interaction methods that garner the most benefits from an online platform
  • Evaluate your clinical infrastructure’s readiness to go virtual
  • Maintain patient centricity and patient input in all clinical trial methods

Who Should Attend?

You will benefit from attending this event if you are a professional in the pharmaceutical, biotech, or medical device sectors, with responsibility in the following areas:

  • Clinical Trials
  • Clinical Research
  • Clinical Operations
  • Clinical Supply Chain
  • Clinical Regulatory Affairs
  • Decentralized Trials
  • Remote Monitoring
  • Mobile
  • Wearables
  • Technology
  • Clinical Innovation
  • Patient Recruitment
  • Patient Experience
  • Medical Advisors

Monday

November 16th, 2020 | Day 1

9:00 AM - 9:15 AM

Chairperson’s Opening Remarks

Craig Lipset - Founder
CLINICAL INNOVATION PARTNERS

9:15 AM - 10:00 AM

Guide Technology Providers to Confront their “Unknown Unknowns”

  • Communicate the level of validation needed in order to make claims on data
  • Upgrade due diligence around the technologies that clinical trial teams must have in place
  • Bridge gaps in levels of inherent knowledge

Lesley Schofield - Director of Clinical Trial Operations, U S Medical Affairs
NOVARTIS

10:00 AM - 10:45 AM

Global Considerations for Hybrid Decentralized Studies

  • Explore select differences in launching hybrid decentralized studies in Europe, Asia Pacific and South America
  • Discuss flexible approaches for eConsent, telehealth, eCOA sensors and home health
  • Review lessons learned to date with global DCT expansion

John Reites - President
THREAD

10:45 AM - 11:00 AM

BREAK

11:00 AM - 11:45 AM

PANEL: Emphasize and Maintain Patient Centricity

  • Reduce the need for site visits through at-home monitoring
  • Gather and reliably archive patient feedback on drug formulation and delivery
  • Turn a challenging time into new opportunity, with trial structures that more easily fit into patients’ routines

Alka Shaunik - Global Therapy Area Head, Cardiovascular & Metabolism, Medical Affairs
CSL BEHRING

Vanessa Gertsen - Head, Recruitment Strategy, Clinical Trial Engagement & Enrollment
BRISTOL-MYERS SQUIBB

Jen Horonjeff - Patient Advocate, CEO
SAVVY COOPERATIVE

11:45 AM - 12:30 PM

Navigating the Complexity of the Adoption of Virtual Trials

  • Explore the potential of remote models
  • Recognize and adapt to burdens and complexities of multiple stakeholders
  • Evaluate vendor capabilities to move beyond virtual sites and take on both CRO and site capabilities

Emily Kunka - Digital Transformation Project Lead
UCB

Michelle Luo - Head, Global Evidence & Outcomes
TAKEDA

12:30 PM - 1:00 PM

Lunch

1:00 PM - 1:45 PM

Regulatory Considerations for Virtual Clinical Trials

  • Understand the regulatory guidance available and consider the implications to the regulatory strategy for products that use these novel approaches in clinical trials.
  • Utilize novel approaches to clinical trials within a context of COVID-19
  • Explore the US FDA guidance documents published related to COVID-19 pandemic and provide regulatory insights as to moving forward in our ‘new normal’ of clinical trial development.

Dimitri Talantov - Sr. Director Medical Affairs Clinical Trial Innovation
JANSSEN

1:45 PM - 2:30 PM

Presentation by MEDIDATA

Creating the Clinical Trial Launch Pad: Utilizing a Single Destination for Virtualization

  • Leverage a single destination for all trial virtualization technologies
  • Incorporate and harness the patient voice in the design of a decentralized trial
  • Improve patient access to clinical trials using registries

Michael Tucker - Senior Product Solutions Specialist
MEDIDATA, a Dassault Systèmes Company

Alicia Staley - Senior Director, Patient Engagement
MEDIDATA, a Dassault Systèmes Company

2:30 PM - 2:45 PM

Networking Break

2:45 PM - 3:30 PM

PANEL: Strengthen the Implementation of Virtual Clinical Trials

  • Review how the industry combines conventional strategies with virtual trials
  • Restructure internal processes as needed for implementation
  • Investigate the most cost-effective applications and outcomes
  • Analyze how digital health tools can move trials forward
  • Ensure the data integrity and subjects' safety monitoring in the virtual clinical trials implementation

Elizabeth Stoner - Senior Clinical Advisor
ALLOVIR

Nancy Sacco - VP, Clinical Development
MEITHEAL SPECIALTY PHARMA

Safwan Kezbor - Medical Director, Clinical Development
SHIONOGI

T.J. Sharpe - Patient Advocate
TJSharpe.com

Tuesday

November 17th, 2020 | Day 2

9:00 AM - 9:15 AM

Chairperson’s Recap of Day One

Craig Lipset - Founder
CLINICAL INNOVATION PARTNERS

9:15 AM - 10:00 AM

PANEL: What Does Long-Term Commitment to Decentralized Trials Look Like?

  • Explore areas requiring change in order to drive sustaining adoption in the organization
  • Discuss specific examples spanning processes, vendor selection, training and protocol authoring
  • Share experiences managing organizational change to recognize pitfalls and drivers of success

Moderator:
Craig Lipset - Founder 
CLINICAL INNOVATION PARTNERS

Hassan Kadhim - Director, Global Head of Clinical Trial Business Capabilities and Clinical Innovation
BRISTOL MYERS SQUIBB

Mike Collins - Senior VP, Clinical Operations & Data Sciences
AKEBIA THERAPEUTICS

Sharon Terry - Patient Advocate, Founder and CEO
Genetic Alliance

10:00 AM - 10:45 AM

Is your Clinical Trial Model an Amazon or a Radio Shack? Parallels Between Patient-Centricity in Clinical Trials and Customer Focus in Consumer Businesses

  • Hear the insights gained from designing and implementing transformational solutions for the new era that will propel the future of drug development
  • Discover how to use a lens of business-to-consumer product evolution
  • Examine actual client needs from this past year as case studies showing how we can shape an “Amazon experience”
  • Identify and increase focus on patients and evolving customer needs to deliver solutions that are relevant and long-lasting

Dr. Bola Oyegunwa - Vice President and Head of Virtual Trials
COVANCE 

10:45 AM - 11:00 AM

BREAK

11:00 AM - 11:45 AM

Ensure Participant Adherence and Compliance in Virtual Trials

  • Outline how the proper technology choices can help or hinder you
  • Compare and contrast technical platform options
  • Focus on the clinical trial without commercial consideration

Michael Song - Senior Manager, Head of Device Functionality, Safety, and Digital Connectivity
ASTRAZENECA

11:45 AM - 12:30 PM

Make Breakthroughs with Virtual Clinical Investigator Meetings

  • Evaluate the benefits of virtual meetings in terms of cost and convenience
  • Compare different methods for gathering information through “breakouts
  • Review new outreach options for CRAs and training
  • Clarify in advance the needs for tech support

Nina Renner-Thomas - Clinical Project Lead, Manager, Clinical Operations
JUUL Labs

12:30 PM - 1:00 PM

Lunch

1:00 PM - 1:45 PM

Artificial Intelligence and Machine Learning in Virtual Trials: Separate Potential from Best Practice

  • Explore the most up-to-date options for large-scale data analysis for virtual trials
  • Address common mistakes and misperceptions
  • Clarify what is realistically possible for digital health and bioinformatics in a remote setting

Shameer Khader - Senior Director, Data Science, Digital Health, and Bioinformatics
ASTRAZENECA

1:45 PM - 2:30 PM

Risk-Based Monitoring and Site Management Applications

  • Determine the most important indicators of site quality
  • Plan creative collaboration and flexible strategies
  • Find the fastest techniques for site quality maximization
  • Recognize how behavior influences team results

Daniella Hensley - Director, Global Clinical Operations
JANSSEN

Wendy Wu - Director, Clinical Development
JAZZ PHARMACEUTICALS

2:30 PM - 2:45 PM

Networking Break

2:45 PM - 3:30 PM

Prioritize Diversity and Access Among Virtual Clinical Patients

  • Emphasize to pharma companies the importance of clinical patient diversity – both to accurately represent the broader patient population and to meet calls for urgent social change
  • Devise solutions for unequal access to virtual / online services, technology, and infrastructure for clinical trials
  • Learn from successful outreach and engagement between pharma and patient groups

Lorena Kuri - Head, Diversity Strategy
BRISTOL-MYERS SQUIBB

Maimah Karmo - Patient Advocate, CEO
TIGERLILY FOUNDATION

ADVISORY BOARD

Image

Bola Oyegunwa

COVANCE

Head of Hybrid and Virtual Trials

FEATURED SPEAKERS

Image

Craig Lipset

CLINICAL INNOVATION PARTNERS

Founder

Image

Mike Collins

AKEBIA THERAPEUTICS

Senior VP, Clinical Operations & Data Sciences

Image

Vanessa Gertsen

BRISTOL-MYERS SQUIBB

Head, Recruitment Strategy, Clinical Trial Engagement & Enrollment

Image

Daniella Hensley

JANSSEN

Director, Global Clinical Operations

Image

Maimah Karmo

TIGERLILY FOUNDATION

Patient Advocate, CEO

Image

Safwan Kezbor

SHIONOGI

Medical Director, Clinical Development

Image

Shameer Khader

ASTRAZENECA

Senior Director, Data Science, Digital Health, and Bioinformatics

Image

Emily Kunka

UCB

Digital Transformation Project Lead

Image

Lorena Kuri

BRISTOL-MYERS SQUIBB

Head, Diversity Strategy

Image

Bibhudatta Mishra

JOHNS HOPKINS MEDICINE

Senior Clinical Trial Scientist

Image

John Reites

THREAD

President

Image

Nina Renner-Thomas

JUUL Labs

Clinical Project Lead, Manager, Clinical Operations

Image

Nancy Sacco

MEITHEAL SPECIALTY PHARMA

VP, Clinical Development

Image

Lesley Schofield

NOVARTIS

Director of Clinical Trial Operations, U S Medical Affairs

Image

Alka Shaunik

CSL BEHRING

Global Therapy Area Head, Cardiovascular & Metabolism, Medical Affairs

Image

Michael Song

ASTRAZENECA

Senior Manager, Head of Device Functionality, Safety, and Digital Connectivity

Image

Elizabeth Stoner

ALLOVIR

Senior Clinical Advisor

Image

Dimitri Talantov

JANSSEN

Sr. Director Medical Affairs Clinical Trial Innovation

Image

Wendy Wu

JAZZ PHARMACEUTICALS

Director, Clinical Development

Image

Jen Horonjeff

SAVVY COOPERTIVE

Patient Advocate, CEO

Image

Hassan Kadhim

BRISTOL MYERS SQUIBB

Director, Global Head of Clinical Trial Business Capabilities and Clinical Innovation

Image

Michelle Luo

TAKEDA

Head, Global Evidence & Outcomes

Image

Claus Torp Jensen

MEMORIAL SLOAN KETTERING CANCER CENTER

Chief Digital Officer and Chief Technology Officer

Image

T.J. Sharpe

TJSharpe.com

Patient Advocate

Image

Sharon Terry

Genetic Alliance

Patient Advocate, Founder and CEO

Image

Michael Tucker

Medidata, a Dassault Systèmes company

Senior Product Solutions Specialist

Image

Alicia Staley

Medidata, a Dassault Systèmes company

Senior Director, Patient Engagement

CONFERENCE REGISTRATION

LIVESTREAM PRICING

STANDARD

$896


Register Anytime

Register 2 Attendees, Get 1 Complimentary Registration!*

Interested in registering groups of 7 or more? Contact us directly for pricing.

SPONSORED BY

Scarritt Group - Official Livestream Provider

OFFICIAL LIVESTREAM PROVIDER

MEDIA PARTNERS

PM360 - Media Partner

PREMIER MEDIA PARTNER


SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571-7687achapman@dgeconfs.com